MSM Protein Technologies, Inc.
Pioneering novel methods for precise targeting of challenging therapeutic proteins in drug discovery.
5 employees · est. 2005
Numab Therapeutics AG
Multi-specific antibodies that enable the pursuit of novel therapeutic strategies.
68 employees · est. 2011 · Horgen, Switzerland
MSM Protein Technologies, Inc. is the older company (2005 vs 2011); Numab Therapeutics AG is the larger of the two.
Side-by-Side Comparison
| Metric | MSM Protein Technologies, Inc. | Numab Therapeutics AG |
|---|---|---|
| Founded | ||
| Founded | 2005 older | 2011 |
| Headquarters | ||
| Headquarters | Not tracked yet | Horgen, Switzerland |
| Employees | ||
| Employees | 5 | 68 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Information Technology | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Seed | Series C |
| Total Funding | ||
| Total Funding | $250.00K | $122.00M |
| Funding Rounds | ||
| Funding Rounds | 1 | 3 |
| Services | ||
| Services | antibody drug development, pre-clinical stage antibody pipeline, human antibody generation against membrane proteins | Not tracked yet |
| Target Customers | ||
| Target Customers | pharmaceutical companies, biotechnology firms, medical research organizations | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Drug Discovery, Functional Antibodies, Multi-spanning Membrane Proteins, Therapeutic Proteins, GPCR Targeting, Ion Channel Targeting, Transporter Targeting, Proprietary Tools, Therapeutic Intervention, Membrane Protein Targeting, Biotech Innovation, Antibody Discovery, Protein Technologies, Precision Targeting | Multi-specific Antibodies, Therapeutic Strategies, Immunotherapies, Inflammation, Cancer, Drug Discovery, Pipeline, Precision Medicine, Atopic Dermatitis, Therapeutic Design, Patient Benefits, Innovation, Biopharmaceuticals |
| Website | ||
| Website | msmprotein.com | numab.com |
About MSM Protein Technologies, Inc.
MSM Protein Technologies, Inc. stands at the forefront of biotechnology innovation with its niche focus on pioneering novel methods for the precise targeting of complex therapeutic proteins in drug discovery. Founded in 2005, this enterprise leverages its proprietary tools to enhance the discovery o...
About Numab Therapeutics AG
Numab Therapeutics AG is a Swiss-based biopharmaceutical company founded in 2011. The company specializes in developing multi-specific antibody-based immunotherapies for inflammation and cancer. With a proprietary platform called λ-Cap™ and MATCH™, Numab has a unique advantage in overcoming historic...
We will tell you when either one moves
BounceWatch watches MSM Protein Technologies, Inc. and Numab Therapeutics AG for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at MSM Protein Technologi... and Numab Therapeutics AG — by email.
Frequently Asked Questions
Compare MSM Protein Technologies, Inc. with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at MSM Protein Technologies, Inc. on 24 Mar 2026, and Numab Therapeutics AG on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
